SEQUA — Sequana Medical NV Income Statement
0.000.00%
Last trade - 00:00
- €45.37m
- €60.30m
- €0.71m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.971 | 0.963 | 0.37 | 0.923 | 0.712 |
Cost of Revenue | |||||
Gross Profit | -0.158 | -0.875 | -2.42 | -2.44 | -4.18 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 14.9 | 18.7 | 23 | 29 | 29.6 |
Operating Profit | -14 | -17.8 | -22.6 | -28.1 | -28.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -14.8 | -18.9 | -23.2 | -30.4 | -32.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -15 | -19.1 | -23.6 | -30.8 | -32.6 |
Net Income Before Extraordinary Items | |||||
Net Income | -15 | -19.1 | -23.6 | -30.8 | -32.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -15 | -19.1 | -23.6 | -30.8 | -32.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.19 | -1.23 | -1.3 | -1.35 | -1.22 |